These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15247177)

  • 1. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.
    Forcione DG; Rosen MJ; Kisiel JB; Sands BE
    Gut; 2004 Aug; 53(8):1117-22. PubMed ID: 15247177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
    Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
    Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
    Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients.
    Amre DK; Lu SE; Costea F; Seidman EG
    Am J Gastroenterol; 2006 Mar; 101(3):645-52. PubMed ID: 16464223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease.
    El-Matary W; Dupuis K; Sokoro A
    Acta Paediatr; 2015 Aug; 104(8):827-30. PubMed ID: 25877674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S; O'Sullivan M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease.
    Barta Z; Csípõ I; Szabó GG; Szegedi G
    World J Gastroenterol; 2003 Oct; 9(10):2308-12. PubMed ID: 14562398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease.
    Kotze LM; Nisihara RM; Utiyama SR; Kotze PG; Theiss PM; Olandoski M
    Arq Gastroenterol; 2010; 47(3):242-5. PubMed ID: 21140083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibodies and anthropometric data at diagnosis in pediatric Crohn's disease.
    Trauernicht AK; Steiner SJ
    Dig Dis Sci; 2012 Apr; 57(4):1020-5. PubMed ID: 22075854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Saccharomyces cerevisiae Antibodies as a Prognostic Biomarker in Children With Crohn Disease.
    Chandrakumar A; Georgy M; Agarwal P; 't Jong GW; El-Matary W
    J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):82-87. PubMed ID: 30789863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.
    Lawrance IC; Murray K; Hall A; Sung JJ; Leong R
    Am J Gastroenterol; 2004 Nov; 99(11):2186-94. PubMed ID: 15555001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.
    Zhang Z; Li C; Zhao X; Lv C; He Q; Lei S; Guo Y; Zhi F
    Dig Dis Sci; 2012 Nov; 57(11):2944-54. PubMed ID: 22669207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease].
    Le Goff C; Chapelle JP; Lutteri L
    Ann Biol Clin (Paris); 2007; 65(6):601-8. PubMed ID: 18039604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic antibodies in relation to outcome in postoperative Crohn's disease.
    Hamilton AL; Kamm MA; De Cruz P; Wright EK; Selvaraj F; Princen F; Gorelik A; Liew D; Lawrance IC; Andrews JM; Bampton PA; Sparrow MP; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Bell SJ; Brown SJ; Connell WR
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1195-1203. PubMed ID: 27976801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.